Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases

Endocr Relat Cancer. 2017 Feb;24(2):L21-L25. doi: 10.1530/ERC-16-0419. Epub 2017 Jan 3.

Authors

Anna Karpathakis^{1

2}, Harpreet Dibra¹, Christodoulos Pipinikas¹, Andrew Feber¹, Tiffany Morris¹, Joshua Francis³, Dahmane Oukrif¹, Dalvinder Mandair^{1

2}, Marinos Pericleous², Mullan Mohmaduvesh², Stefano Serra⁴, Olagunju Ogunbiyi³, Marco Novelli¹, TuVinh Luong², Sylvia L Asa⁴, Matthew Kulke⁵, Christos Toumpanakis², Tim Meyer^{1

2}, Martyn Caplin², Stephan Beck¹, Christina Thirlwell^{6

2}

Affiliations

¹ University College LondonLondon, UK.
² 2The Royal Free HospitalLondon, UK.
³ The Broad InstituteBoston, Massachusetts, USA.
⁴ UHN Princess Margaret Cancer CentreToronto, Ontario, Canada.
⁵ DanaFaber Cancer InstituteBoston, Massachusetts, USA.
⁶ University College LondonLondon, UK [email protected].

PMID: 28049633
DOI: 10.1530/ERC-16-0419

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Epigenomics
Female
Humans
Liver Neoplasms / pathology
Liver Neoplasms / secondary*
Male
Neoplasm Metastasis
Neuroendocrine Tumors / complications*
Neuroendocrine Tumors / pathology

Grants and funding